[HTML][HTML] JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

Q Hu, Q Bian, D Rong, L Wang, J Song… - … in Bioengineering and …, 2023 - frontiersin.org
Janus kinase/signal transduction and transcription activation (JAK/STAT) pathways were
originally thought to be intracellular signaling pathways that mediate cytokine signals in …

[HTML][HTML] Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

C Xue, Q Yao, X Gu, Q Shi, X Yuan, Q Chu… - Signal transduction and …, 2023 - nature.com
The Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway
is an evolutionarily conserved mechanism of transmembrane signal transduction that …

CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma

M Gauthier, SL Kale, TB Oriss, M Gorry… - Journal of Allergy and …, 2023 - Elsevier
Background Type 1 (T1) inflammation (marked by IFN-γ expression) is now consistently
identified in subsets of asthma cohorts, but how it contributes to disease remains unclear …

[HTML][HTML] Th17. 1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma

AM Leipold, RA Werner, J Düll, P Jung, M John… - Leukemia, 2023 - nature.com
Pseudo-progression and flare-up phenomena constitute a novel diagnostic challenge in the
follow-up of patients treated with immune-oncology drugs. We present a case study on …

[HTML][HTML] Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade

L Francis, D McCluskey, C Ganier, T Jiang… - Nature …, 2024 - nature.com
Biologic therapies targeting the IL-23/IL-17 axis have transformed the treatment of psoriasis.
However, the early mechanisms of action of these drugs remain poorly understood. Here …

[HTML][HTML] Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches

ON Obi, LA Saketkoo, AM Russell… - Frontiers in …, 2022 - frontiersin.org
Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …

Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial

A Redl, K Doberer, L Unterluggauer… - The Lancet …, 2024 - thelancet.com
Background Sarcoidosis is an inflammatory condition that can affect various organs and
tissues, causing the formation of granulomas and subsequent functional impairment. The …

Personalized medicine in sarcoidosis: unravelling biomarkers for targeted care

J Francesqui, P Marrades… - Current opinion in …, 2023 - journals.lww.com
These findings have implications for clinical practice and research. The limitations of
established biomarkers underscore the need for improved diagnostic tools in sarcoidosis …

Multinucleation resets human macrophages for specialized functions at the expense of their identity

K Ahmadzadeh, M Pereira, M Vanoppen… - EMBO …, 2023 - embopress.org
Macrophages undergo plasma membrane fusion and cell multinucleation to form
multinucleated giant cells (MGCs) such as osteoclasts in bone, Langhans giant cells (LGCs) …

[HTML][HTML] Sarcoidosis and COVID-19: at the cross-road between immunopathology and clinical manifestation

C Tana, F Cinetto, C Mantini, N Bernardinello, M Tana… - Biomedicines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) has been associated with dysregulation of the
immune system featuring inappropriate immune responses, exacerbation of inflammatory …